One study in PC-3/PC-3-PIP-tumor-bearing mice compared the effects of [177Lu]Lu-PSMA617 with [225Ac]Ac-PSMA617, finding improved overall antitumor effectiveness and enhanced therapeutic efficacy for [225Ac]Ac-PSMA-617 [79]. The gene discussed is FOLH1; the disease is neoplasm.